adalimumab
Commercial- Indications
- Rheumatoid arthritis, Crohn's disease, Psoriasis
Company intelligence / Profile preview
Fresenius delivers commercialized products and services globally in dialysis, hospital management, clinical nutrition, generic injectables, and medical devices. Its subsidiary Fresenius Medical Care leads the global dialysis market with over four million patients treated worldwide annually. The group continues to expand its product lines—such as recent launches of new epinephrine injectables—and invests heavily in manufacturing innovation.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius.